Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03919721
Other study ID # Motivity-II
Secondary ID R44MH098476
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 1, 2019
Est. completion date March 31, 2020

Study information

Verified date April 2019
Source Experiad LLC
Contact Rex Jakobovits, PhD
Phone 2065885811
Email clinicaltrials@motivity.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a study funded by a Phase II SBIR to build and test the feasibility of a new software prototype for delivering evidence-based behavioral therapy treatment for autism. The software, called Motivity.net, will be used by behavioral therapy provider groups across the country to manage the intensive data collection and analysis workflow associated with Applied Behavioral Analysis (ABA) and related therapies, which are becoming standard-of-care treatment for children with autism.


Description:

This is a study funded by a Phase II SBIR to build and test the feasibility of a new software prototype for delivering evidence-based behavioral therapy treatment for autism. The software, called Motivity.net, will be used by behavioral therapy provider groups across the country to manage the intensive data collection and analysis workflow associated with Applied Behavioral Analysis (ABA) and related therapies, which are becoming standard-of-care treatment for children with autism. Experiad will conduct an 8-week within-subject pilot study of 6 BCBAs, 12 BTs and 12 children to answer product research questions about Motivity's ability to perform its intended functions, measuring the degree to which it allows interventionists to encode their models, achieve more efficient program management, improve communication, and increase responsiveness to a child's progress. Experiad will also use descriptive statistics to provide preliminary insight into the potential impact of the system on a child's performance in their ABA therapy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 12
Est. completion date March 31, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers No
Gender All
Age group 2 Years to 21 Years
Eligibility Inclusion Criteria:

- Child receiving applied behavior analysis at participating institution to treat autism disorder

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Applied Behavioral Analysis
Children are receiving Applied Behavioral Analysis therapy to treat their autism. Therapy is comprised of 15-20 discrete programs that are intended to shape specific behaviors. Tutors collect data on child's performance towards goals. For each child, some of the programs will be tracked with paper data collection methods, others will use electronic data collection. This study is to test the usefulness of the electronic data collection system to replace paper in existing interventions.

Locations

Country Name City State
United States Northwest Behavioral Associates Bellevue Washington

Sponsors (4)

Lead Sponsor Collaborator
Experiad LLC National Institute of Mental Health (NIMH), northwest behavioral associates, University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Impact of software on number of updates to programs made by behavior analysts (intervention agility) Comparing the frequency of program updates between electronic programs and paper programs Data will be collected continuously from start to end of study; totals will be analyzed at the end of study (8 weeks from start date)
Primary Event tracking usability assessed by user ratings Number of tutors who rate it highly on likert scale Likert scale to be administered at the end of study (8 weeks from start date)
Primary Program editing efficiency as assessed by usage analysis Comparison of total time spent editing electronic programs vs paper programs. Time will be tracked continuously from start to end of study; totals will be analyzed at the end of study (8 weeks from start date)
Primary Impact of software on trial success rate Comparison of overall trial success rate (percent of trails meeting success threshold) in electronic administered programs compared to paper administered programs Data will be collected continuously from start to end of study; totals will be analyzed at the end of study (8 weeks from start date)
Primary Impact of software on trials to criterion (number of trials needed to achieve mastery) Comparison of trials to criterion (number of trials needed to achieve mastery) in electronic administered programs compared to paper administered programs Data will be collected continuously from start to end of study; totals will be analyzed at the end of study (8 weeks from start date)
Primary Impact of software on total number of targets mastered Comparison of total number of targets mastered in electronic administered programs compared to paper administered programs Data will be collected continuously from start to end of study; totals will be analyzed at the end of study (8 weeks from start date)
See also
  Status Clinical Trial Phase
Recruiting NCT03222375 - SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT02568631 - Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls N/A
Completed NCT02708290 - Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
Completed NCT02369445 - Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention N/A
Completed NCT01617460 - A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder Phase 3
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01400269 - An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism N/A
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Completed NCT00926471 - Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders Phase 1
Completed NCT00692315 - Treating Oxidative Stress in Children With Autism N/A
Completed NCT00365859 - Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) Phase 3
Completed NCT00198107 - Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism Phase 3
Completed NCT00095420 - Relationship Training for Children With Autism and Their Peers N/A
Completed NCT00027404 - Study of Fluoxetine in Adults With Autistic Disorder N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT04820998 - Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care
Withdrawn NCT05413187 - A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder Phase 2
Recruiting NCT02275455 - Design Of WELL Being Monitoring Systems, Application in Autism N/A
Completed NCT02766101 - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges N/A
Completed NCT01977248 - Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12 N/A